Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Omega Healthcare (NYSE:OHI) Concludes FY24 with 68% Surge in Net Income, Maintains Positive Outlook for 2025

Omega Healthcare Investors, Inc. (NYSE:OHI)is a real estate investment trust (REIT)and it operates through a single segment, which invests in healthcare-related real estate properties located in the US and the UK.

Team Kalkine | 29 March 2025

Woodside Energy (NYSE: WDS) Sells Greater Angostura Assets in Trinidad and Tobago for $206Mn

Woodside Energy (NYSE: WDS) has entered into an agreement with Perenco to sell its Greater Angostura assets in Trinidad and Tobago for $206 million. The divestment includes Woodside’s interest in the Angostura and Ruby offshore oil and gas fields, along with the associated production …

Team Kalkine | 28 March 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Receives Approval for Dupixent® in Japan for COPD Treatment

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted marketing and manufacturing authorization for Dupixent® (dupilumab) to treat chronic obstructive pulmonary disease (COPD) in adults whose condition is not well-managed with existing therapies. This …

Team Kalkine | 28 March 2025

Pony.ai (NASDAQ: PONY) Expands Paid Driverless Robotaxi Operations in Shenzhen

Pony.ai (NASDAQ: PONY) achieved a significant milestone on March 27, 2025, as the first company authorized to operate paid fully-driverless robotaxi services in Shenzhen's Nanshan District. This marks a key moment in the city's progress toward offering autonomous ride-hailing services in its urban centers.

Team Kalkine | 28 March 2025

Yiren Digital Forms Strategic Joint Venture to Advance AI-Driven Financial Solutions in Southeast Asia

Yiren Digital partners with AG Networkto develop AI-powered financial solutions for Indonesia.

Team Kalkine | 27 March 2025

Innate Pharma Reports 2024 Financial Results and Clinical Advancements

Lacutamab granted FDA Breakthrough Therapy Designationfor relapsed or refractory Sézary syndrome.

Team Kalkine | 27 March 2025

IFF and Kemira Launch Alpha Bio to Advance Biobased Materials

€130 Million Investment:Alpha Bio will establish a commercial-scale biopolymer production facility in Finland.

Team Kalkine | 27 March 2025

Greenland Technologies Reports Turnaround in 2024 Financial Results, Operational Efficiency and Cost Reductions Drive Profitability

28% reduction in operating expenses, down to$9.9 millionfrom$13.8 millionin 2023.

Team Kalkine | 26 March 2025